Satsuma Pharmaceuticals, Inc. price (STSA)

About Satsuma Pharmaceuticals, Inc.

Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA.